Get in touch with from Blusense
Provider of next-generation POCT platform designed to diagnose infectious diseases. The company's platform is developing a consumer-oriented point-of-care blood testing device based on a nanotechnology biosensing method that can deliver results in a few minutes with a single drop of blood, enabling people to monitor, control and manage virus outbreaks better.
The firm's innovative dengue/COVID-19 rapid diagnostic tool is specifically designed for use in emerging markets and provides a climate adaptive product that helps equip affected populations with the required instruments to adjust to more frequent incidences of vector borne diseases.
- 3, Fruebjergvej, København, Denmark
- Countries of operation
- Malaysia, Vietnam, Thailand, India, Costa Rica, Panama, Colombia, Peru
- Year Founded
- View Website
- Human and Managed Systems
- Impacts to human health, and loss of livelihoods, Spread of pests, and vector-borne and water- borne diseases
- Generating revenue?
- Prefer not to say
- Company stage
Last updated: May 25, 2021